Company intelligence / Profile preview

Syntex Corporation

Palo Alto, California, United Stateslearn.microsoft.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Syntex was known for pioneering the birth control pill and developing Naprosyn, which became the leading arthritis drug and fifth best-selling drug in the world in the 1980s.

Therapeutic areas
Infectious DiseasesCardiovascularRheumatologyWomen's Health
Modalities
Small moleculessteroid hormones
Industry
Pharma
02

Drug pipeline

1 asset

fluocinolone acetonide

Approved
03

Partnerships

Eli Lilly and CompanyJohnson & JohnsonScheringCiba-GeigyVarian Associates (joint venture)

Beyond the preview

Go deeper on Syntex Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syntex Corporation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call